Niraparib synthesis method

A synthetic method and synthetic route technology, applied in the field of synthesis of Niraparib, can solve problems such as difficult to realize large-scale industrial production, limit industrial safety production, long synthetic route, etc., achieve large-scale production, easy large-scale production, The effect of easy control of operating conditions

Inactive Publication Date: 2017-03-01
SHAANXI UNIV OF SCI & TECH
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The synthetic route is relatively long, and Niraparib obtained by using Chiralpak AS-H normal phase chiral chromatographic column is not easy to achieve large-scale industrial production, and unstable and difficult post-processing raw materials such as sodium azide are used in the reaction, which limits industrialization Safe Production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Niraparib synthesis method
  • Niraparib synthesis method
  • Niraparib synthesis method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Niraparib intermediate 1 Synthesis

[0038]The synthesis of Niraparib intermediate 1 is carried out in two steps, the first step (esterification): 3-methyl-2-nitrobenzoic acid and methyl alcohol are pressed by n (3-methyl-2-nitrobenzoic acid): The ratio of n (methanol) = 1:5, that is, take 182g of 3-methyl-2-nitrobenzoic acid, place 160.2g of methanol in a conical flask with a reflux device, heat slowly, and wait for 3-methyl-2- After the nitrobenzoic acid was completely dissolved in methanol, 6 mL of concentrated sulfuric acid was added, and the temperature was raised to 58°C for the reaction. The product was methyl 3-methyl-2-nitrocarboxylate (Niraparib intermediate 1) and water. The generated Niraparib intermediate 1 is subjected to the second step (refinement and extraction): after the esterification reaction is completed, after the temperature of the reaction solution drops to room temperature, adjust the pH of the solution to neutral with sodium bicarbonate, and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a Niraparib synthesis method. The method comprises that through esterification, 3-methyl hydroformylation, 3-schiff base reaction, cyclization, amidation, BOC removal and chiral resolution, optically pure Niraparib with purity of 91% or more is prepared from 3-methyl-2-nitrobenzoic acid. The method has the advantages of simple process, high efficiency, easy operation and less equipment requirement, and is a method suitable for industrial production.

Description

technical field [0001] The invention relates to the synthesis of anticancer drugs, in particular to a synthesis method for preparing Niraparib. Background technique [0002] The chemical name of Niraparib is 2-[4-((3S)-3-piperidinyl)phenyl]-2H-indazole-7-carboxamide, which is an oral poly ADP ribose polymerase (PARP) inhibitor, Inhibits cellular repair of DNA damage. For cancer cells with BRCA gene mutations, if PARP activity is further inhibited, these cells will generate a lot of DNA damage when they divide, leading to the death of cancer cells. However, normal cells can still repair DNA without PARP because of the presence of BRCA, but the effect is worse, but they can survive. This is why PARP inhibitors act as targeted drugs to selectively kill BRCA mutant cancer cells. Niraparib is suitable for cancers with BRCA1 / 2 gene mutations, such as ovarian cancer and breast cancer, and was developed by Tesaro, an American biotechnology company. A phase III clinical trial cal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/10
CPCC07D401/10C07B2200/13
Inventor 梁承远贾敏一田丹妮
Owner SHAANXI UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap